Gridelli, C <br/><br/>
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Dec 1995 
 - 2424-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Letter 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/0959-8049(95)00403-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Carcinoma, Small Cell--drug therapy<br/>Carmustine--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged